Certain bone marrow lesions can help identify patients who are likely to suffer from rapidly progressing osteoarthritis.

Even in remission, a sizeable proportion of patients report symptoms suggestive of neuropathic pain.

In the past 15 years, the number of deaths from cardiovascular disease has decreased significantly in people with rheumatoid arthritis.

The presence of tophi in people with gout was associated with increased risk for cardiovascular disease.

Footwear and orthoses can provide relief for those experiencing pain from osteoarthritis of the first MTP joint.

Researchers quantified the heritability and genetic sharing for 9 pediatric autoimmune disorders.

Optimal NSAID therapy reduces the intensity of bone marrow edema in patients with axial spondyloarthritis.

Research shows that incident gout rates are higher among patients with sleep apnea.

A 16-week, open-label extension of the REALISTIC phase 3b trial shows rapid and sustained clinical improvements with certolizumab pegol in patients with RA.

Recent data show that tocilizumab is associated with improved quality of life without aggressive steroid treatment in patients with polymyalgia rheumatica.

Survivors of cancer in childhood are more susceptible to autoimmune disorders.

Patients with rheumatoid arthritis treated during the biologic treatment era exhibited clinical remission or low disease activity on follow-up, according to study data published in the Journal of Rheumatology.

A targeted treatment approach may provide benefit for patients with psoriatic arthritis.

The American College of Physicians updated the guidelines for the practice of concierge medicine.

A study examines the association between wrist fractures and subsequent fracturing in postmenopausal women.

Both early intervention and targeted treatment more effectively treat psoriatic arthritis than standard care, according to data published in The Lancet.

Integral to timely and effective diagnosis and treatment, key performance indicators have been developed to evaluate central intake systems for osteoarthritis and rheumatoid arthritis.

Two studies from the American College of Rheumatology annual meeting suggest that diet can affect risk of developing rheumatoid arthritis.

Systemic lupus erythematosus disease activity can be assessed using IL-6 and IL-17 baseline serum levels as biomarkers.

Among those deciding to escalate care, 32% in the intervention group met the criteria for making an informed decision compared with 13% in the control group.

Rheumatoid arthritis mortality rates have decreased since 2000 due to better treatment options.

Cyclophosphamide and mycophenolate mofetil efficacious for scleroderma-related lung disease, according to trial data reported at ACR/ARHP 2015.

Tocilizumab was associated with significant improvement in periodontal inflammation in patients with RA.

Chondroitin sulfate reduced long-term progression of structural changes in patients with knee osteoarthritis.

Recent research has identified new targeted therapies for psoriasis and psoriatic arthritis.